Annual Cash & Cash Equivalents
$46.51 M
+$35.44 M+320.30%
December 31, 2023
Summary
- As of February 8, 2025, MXCT annual cash & cash equivalents is $46.51 million, with the most recent change of +$35.44 million (+320.30%) on December 31, 2023.
- During the last 3 years, MXCT annual cash & cash equivalents has risen by +$27.75 million (+147.96%).
- MXCT annual cash & cash equivalents is now -2.67% below its all-time high of $47.78 million, reached on December 31, 2021.
Performance
MXCT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$36.96 M
-$555.00 K-1.48%
September 30, 2024
Summary
- As of February 8, 2025, MXCT quarterly cash and cash equivalents is $36.96 million, with the most recent change of -$555.00 thousand (-1.48%) on September 30, 2024.
- Over the past year, MXCT quarterly cash and cash equivalents has dropped by -$12.21 million (-24.84%).
- MXCT quarterly cash and cash equivalents is now -84.59% below its all-time high of $239.78 million, reached on March 31, 2022.
Performance
MXCT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MXCT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +320.3% | -24.8% |
| 3 y3 years | +148.0% | +234.0% |
| 5 y5 years | +313.5% | +234.0% |
MXCT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.7% | +320.3% | -84.6% | +234.0% |
| 5 y | 5-year | -2.7% | +320.3% | -84.6% | +234.0% |
| alltime | all time | -2.7% | +5980.0% | -84.6% | +1432.3% |
MaxCyte Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $36.96 M(-1.5%) |
| Jun 2024 | - | $37.51 M(+68.6%) |
| Mar 2024 | - | $22.25 M(-52.2%) |
| Dec 2023 | $46.51 M(+320.3%) | $46.51 M(-5.4%) |
| Sep 2023 | - | $49.17 M(-9.9%) |
| Jun 2023 | - | $54.56 M(+44.2%) |
| Mar 2023 | - | $37.83 M(+241.9%) |
| Dec 2022 | $11.06 M(-76.8%) | $11.06 M(-74.3%) |
| Sep 2022 | - | $43.02 M(-60.6%) |
| Jun 2022 | - | $109.17 M(-54.5%) |
| Mar 2022 | - | $239.78 M(+401.8%) |
| Dec 2021 | $47.78 M(+154.8%) | $47.78 M(-19.0%) |
| Sep 2021 | - | $58.97 M(+57.6%) |
| Jun 2021 | - | $37.42 M(+99.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $18.76 M(+23.3%) | $18.76 M(-50.9%) |
| Jun 2020 | - | $38.17 M(+151.0%) |
| Dec 2019 | $15.21 M(+35.2%) | $15.21 M(+32.6%) |
| Jun 2019 | - | $11.47 M(+2.0%) |
| Dec 2018 | $11.25 M(-55.6%) | $11.25 M(-29.8%) |
| Jun 2018 | - | $16.02 M(-36.8%) |
| Dec 2017 | $25.34 M(+116.1%) | $25.34 M(-16.0%) |
| Jun 2017 | - | $30.16 M(+157.2%) |
| Dec 2016 | $11.73 M(+386.2%) | $11.73 M(-3.7%) |
| Jun 2016 | - | $12.18 M(+405.0%) |
| Dec 2015 | $2.41 M(-29.2%) | $2.41 M(-83.1%) |
| Jun 2015 | - | $14.28 M(+318.9%) |
| Dec 2014 | $3.41 M(+345.7%) | $3.41 M |
| Dec 2013 | $764.90 K(-46.1%) | - |
| Dec 2012 | $1.42 M | - |
FAQ
- What is MaxCyte annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MaxCyte?
- What is MaxCyte annual cash & cash equivalents year-on-year change?
- What is MaxCyte quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for MaxCyte?
- What is MaxCyte quarterly cash and cash equivalents year-on-year change?
What is MaxCyte annual cash & cash equivalents?
The current annual cash & cash equivalents of MXCT is $46.51 M
What is the all time high annual cash & cash equivalents for MaxCyte?
MaxCyte all-time high annual cash & cash equivalents is $47.78 M
What is MaxCyte annual cash & cash equivalents year-on-year change?
Over the past year, MXCT annual cash & cash equivalents has changed by +$35.44 M (+320.30%)
What is MaxCyte quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MXCT is $36.96 M
What is the all time high quarterly cash and cash equivalents for MaxCyte?
MaxCyte all-time high quarterly cash and cash equivalents is $239.78 M
What is MaxCyte quarterly cash and cash equivalents year-on-year change?
Over the past year, MXCT quarterly cash and cash equivalents has changed by -$12.21 M (-24.84%)